Long-term Behavioral Recovery in Parkinsonian Rats by Triple Transduction with Dopamine-Biosynthesizing Enzyme Genes

沈扬,樊东升,王立军,康德,中野今治,小泽敬也,永津俊治
DOI: https://doi.org/10.3760/j.issn:1006-7876.2002.01.006
2002-01-01
Abstract:Objective To observe the effect of gene therapy for Parkinson disease by triple transduction with dopamine-biosynthesizing enzyme genes. Methods We constructed high titer purified adeno-associated virus (AAV) vectors containing cDNAs encoding human tyrosine hydroxylase (TH), aromatic L-amino acid decarboxylase (AADC) and GTP cyclohydrolase I (GCH) respectively. AAV-TH, AAV-AADC and AAV-GCH were stereotaxically injected into the denervated striatum of Parkinsonian rat; the expression of TH, AADC or GCH was assayed by using immunohistochemical staining; the rotational behavior was assayed for 1 year.Results The immunohistochemical staining and behavioral testing showed that all of TH, AADC and GCH were expressed stably in the striatum, and the rats treated with AAV-TH, AAV-AADC and AAV-GCH showed more remarkable decrease in rotation rate persisted for at least 1 year, than those treated with AAV-TH and AAV-AADC(P0.01). Conclusion AAV-mediated striatal transgene expression of TH, AADC and GCH is more effective for gene therapy on Parkinsonian rat.
What problem does this paper attempt to address?